Medtronic plc (MDT)
NYSE: MDT · IEX Real-Time Price · USD
77.37
+0.25 (0.32%)
At close: Jul 2, 2024, 4:00 PM
77.00
-0.37 (-0.48%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Medtronic Market Cap
Medtronic has a market cap or net worth of $99.21 billion as of July 2, 2024. Its market cap has decreased by -14.76% in one year.
Market Cap
99.21B
Enterprise Value
116.23B
1-Year Change
-14.76%
Ranking
Category
Stock Price
$77.37
Market Cap Chart
Since December 1, 1998, Medtronic's market cap has increased from $33.29B to $99.21B, an increase of 198.05%. That is a compound annual growth rate of 4.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 98.89B | -9.72% |
Dec 29, 2023 | 109.54B | 5.95% |
Dec 30, 2022 | 103.38B | -25.68% |
Dec 31, 2021 | 139.09B | -11.78% |
Dec 31, 2020 | 157.67B | 3.69% |
Dec 31, 2019 | 152.07B | 24.48% |
Dec 31, 2018 | 122.16B | 11.77% |
Dec 29, 2017 | 109.30B | 11.75% |
Dec 30, 2016 | 97.80B | -9.58% |
Dec 31, 2015 | 108.16B | 52.20% |
Dec 31, 2014 | 71.07B | 24.04% |
Dec 31, 2013 | 57.30B | 38.11% |
Dec 31, 2012 | 41.49B | 2.77% |
Dec 30, 2011 | 40.37B | 1.39% |
Dec 31, 2010 | 39.82B | -18.05% |
Dec 31, 2009 | 48.58B | 38.28% |
Dec 31, 2008 | 35.13B | -38.18% |
Dec 31, 2007 | 56.84B | -7.73% |
Dec 29, 2006 | 61.60B | -11.54% |
Dec 30, 2005 | 69.64B | 15.99% |
Dec 31, 2004 | 60.04B | 1.90% |
Dec 31, 2003 | 58.92B | 5.90% |
Dec 31, 2002 | 55.64B | -10.26% |
Dec 31, 2001 | 62.00B | -14.54% |
Dec 29, 2000 | 72.55B | 66.68% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elevance Health | 123.88B |
Sanofi | 121.86B |
Vertex Pharmaceuticals | 121.15B |
Regeneron Pharmaceuticals | 113.48B |
Boston Scientific | 112.26B |
Cigna | 92.49B |
Gilead Sciences | 84.58B |
Bristol-Myers Squibb Company | 83.28B |